Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial - Quiz - MDSpire

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial

  • By

  • Elizabeth A. R. Garfinkle

  • Renzo Perales-Linares

  • Ryan C. Gimple

  • Alexandra J. Livingstone

  • Kaleigh F. Roberts

  • Omar H. Butt

  • S. Peter Goedegebuure

  • Michael D. McLellan

  • Gue Su Chang

  • Jasreet Hundal

  • Jian Yan

  • Jaye B. Navarro

  • Sophia A. Paxton

  • Srestha Chattopadhyay

  • Neil Cooch

  • Alfredo Perales-Puchalt

  • Konstantina Stavroulaki

  • Sarah Rochestie

  • Joann Peters

  • Beth Junker

  • Jian L. Campian

  • Milan G. Chheda

  • Michael R. Chicoine

  • Albert H. Kim

  • Jon T. Willie

  • Gregory J. Zipfel

  • Joshua L. Dowling

  • Christopher A. Miller

  • Obi L. Griffith

  • Malachi Griffith

  • William E. Gillanders

  • Katherine E. Miller

  • Elaine R. Mardis

  • Niranjan Y. Sardesai

  • Gavin P. Dunn

  • Tanner M. Johanns

  • May 12, 2026

  • 0 min

Share

Original Source(s)

Related Content